Stanley C. Erck, President and CEO at NOVAVAX INC (NVAX), sold 19,564 shares at $107.56 ($2.1M) on 2020-09-30, disclosed to the SEC on 2020-10-01.
Open-market sale of $2.1M NVAX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.56 | 517 | $56K | 2.6% |
| 2 | $107.56 | 517 | $56K | 2.6% |
| 3 | $108.56 | 5,138 | $558K | 26.0% |
| 4 | $108.56 | 5,138 | $558K | 26.0% |
| 5 | $109.54 | 1,500 | $164K | 7.7% |
| 6 | $110.54 | 1,676 |
| $185K |
| 8.6% |
| 7 | $110.54 | 1,676 | $185K | 8.6% |
| 8 | $111.41 | 900 | $100K | 4.7% |
| 9 | $112.65 | 800 | $90K | 4.2% |
| 10 | $114.20 | 700 | $80K | 3.7% |
| 11 | $114.73 | 800 | $92K | 4.3% |
| 12 | $115.43 | 100 | $12K | 0.5% |
| 13 | $115.65 | 100 | $12K | 0.5% |
| 14 | $108.57 | 2 | $217 | 0.0% |
| Total | $109.75 avg | 19,564 | $2.1M | 100% |
| Filing → |
| MXCT | SELL | 2024-10-02 | $358K | — | Filing → |
| MXCT | SELL | 2024-09-05 | $383K | — | Filing → |
| NVAX | SELL | 2021-10-05 | $16.6M | — | Filing → |